Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: Prognostic value of TIMP-1 in severe sepsis

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 10, 2006, Pages 867-872

  Hoffmann, Ursula ^a   Bertsch, Thomas ^b   Dvortsak, Eszter ^a   Liebetrau, Claudia ^a   Lang, Siegfried ^a   Liebe, Volker ^a   Huhle, Guenter ^a   Borggrefe, Martin ^a   Brueckmann, Martina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute of Clinical Chemistry and Laboratory Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MORTALITY; PROGNOSIS; RISK ASSESSMENT; SEPSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEPSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33749354927     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600702058     Document Type: Article

References (24)

1. Birkedal-Hansen, H and Moore, WG and Bodden, MK and Windsor, LJ and Birkedal-Hansen, B and DeCarlo, A and (1993) Matrix metalloproteinases: a review Crit Rev Oral Biol Med, 4, pp. 197-250.
2. Guedez, L and Lim, MS and Stetler-Stevensen, WG. (1996) The role of metalloproteinases and their inhibitors in haematological disorders Crit Rev Oncog, 7, pp. 205-25.
3. Stetler-Stevenson, WG and Liotta, LA and Kleiner, DE, Jr. (1993) Extracellular matrix 6: Role of matrix metalloproteinases in tumour invasion and metastasis FASEB J, 7, pp. 1434-41.
4. Ferroni, P and Basili, S and Martini, F and Cardarello, CM and Ceci, F and Di Franco, M and (2003) Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation J Investig Med, 51, pp. 295-300.
5. Keck, T and Balcom, JHT and Fernandez-del Castillo, C and Bozena, A and Antoniu, BA and Warshaw, AL. (2002) Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in prancreatitis-associated lung injury in the rat Gastroenterology, 122, pp. 188-201.
6. Okada, S and Kita, H and George, TJ and Gleich, GJ and Leifermann, KM. (1997) Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9 Am J Respir Cell Mol Biol, 17, pp. 519-28.
7. Takeshita, S and Tokotomi, T and Kawase, H and Nakatani, K and Tsujimoto, H and Kawamura, Y and (2001) Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease Clin Exp Immunol, 125, pp. 340-4.
8. Oshita, Y and Koga, T and Kamimura, T and Matsuo, K and Rikimaru, T and Aizawa, H. (2003) Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma Thorax, 58, pp. 757-60.
9. Ricou, B and Nicod, L and Lacraz, S and Welgus, HG and Suter, PM and Dayer, JM. (1996) Matrix metalloproteinases and TIMP in acute respiratory distress syndrome Am J Respir Crit Care Med. 154, pp. 346-52.
10. Pugin, J and Widmer, MC and Kossodo, S and Liang, CM and Preas, II HL and Suffredini, AF. (1999) Human neutrophils secrete geatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators Am J Respir Cell Mol Biol, 20, pp. 458-64.
11. Albert, J and Radomski, A and Soop, A and Sollevi, A and Frostell, C and Radomski, MW. (2003) Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers Acta Anaesthesiol Scand. 47, pp. 407-10.
12. Bone, RC and Balk, RA and Cerra, FB and Dellinger, RP and Fein, AM and Knaus, WA and (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Chest, 101, pp. 1644-55.
13. Knaus, WA and Draper, EA and Wagner, D and Zimmermann, JE. (1985) APACHE II: A severity of disease classification system Crit Care Med, 13, pp. 818-29.
14. Opdenakker, G and van den Stehen, PHE and van Damme, J. (2001) Gelatinase B: A tuner and amplifier of immune functions Trends in Immunology, 22, pp. 571-9.
15. Goetzl, EJ and Banda, MJ and Leppert, D. (1996) Matrix metalloproteinases in immunity J Immunol, 165, pp. 1-4.
16. Matsuyama, A and Sakai, N and Ishigami, M and Hiraoka, H and Kashine, S and Hirata, A and (2003) Matrix metalloproteinases as novel disease markers in Takayasu arteritis Circulation, 108, pp. 1469-73.
17. Spittler, A and Razenberger, M and Kupper, H and Kaul, M and Hackl, W and Boltz-Nitulescu, G and (2000) Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production Clin Infect Dis., 31, pp. 1338-42.
18. Remick, DG and Bolgos, G and Copeland, S and Siddiqui, J. (2005) Role of interleukin-6 in mortality from and physiological response to sepsis Infect Immun, 73, pp. 2751-7.
19. Nakamura, T and Ebihara, I and Shimada, N and Shoji, H and Koide, H. (1998) Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fibre-immobilized polymyxin B treatment Am J Med Sci. 316, pp. 355-60.
20. Yassen, KA and Galley, HF and Webster, NR. (2001) Matrix metalloproteinase-9 concentrations in critically ill patients Anaesthesia, 56, pp. 729-32.
21. Chromek, M and Tullus, K and Lundahl, J and Brauner, A. (2004) Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation Infection and Immunity, 72, pp. 82-8.
22. Tayebjee, MH and Lip, GYH and Blann, AD and MacFadyen, RJ. (2005) Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2 Thrombosis Research, 115, pp. 205-10.
23. Dubois, B and Starckx, S and Pagenstecher, A and van den Oord, J and Arnold, B and Opdenakker, G. (2002) Gelatinase B deficiency protects against endotoxin shock Eur J Immunol, 32, pp. 2163-71.
24. Lalu, MM and Gao, CQ and Schulz, R. (2003) Matrix metalloproteinase inhibitors attenuate endotoxaemia induced cardiac dysfunction: A potential role for MMP-9 Mol Cell Biochem, 251, pp. 61-6.